CELLULAR / SINGLE
GHK-CU
50MG · 100MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A naturally occurring copper-binding tripeptide studied in extracellular-matrix signalling, collagen pathways and tissue-remodelling research.
Available Strengths
- 50MG (CU50)
- 100MG (CU100)
Research Protocol
Reference five-days-per-week schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–4 | 1 mg | 6 | 0.06 mL |
| Weeks 5–8 | 1.5 mg | 9 | 0.09 mL |
| Weeks 9–12+ | 2 mg | 12 | 0.12 mL |
Reconstitution
≈16.67 mg/mL once reconstituted
- Draw 3.0 mL of bacteriostatic water per 50 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved. Do not shake.
Research context
Copper-binding activity is studied in relation to collagen and elastin synthesis, antioxidant defence and cellular-repair signalling; most human evidence to date covers topical and wound-care formulations rather than injectable use.
Storage
Follow the verified product label for temperature, moisture and light protection. Minimize light exposure and repeated freeze-thaw cycles; record the preparation date.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
- No approved injectable human protocol exists; the schedule above is a research-use convention from the reference source, not a clinical guideline.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source